ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

Non-steroidal anti-inflammatory drugs (NSAIDs) are liders in selling both in the Russian Federation and worldwide. The combination of analgesic, anti-inflammatory and antipyretic effects make the drugs of this group very popular in patients with various diseases. The realization of NSAIDs in phar...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-09-01
Series:	Безопасность и риск фармакотерапии
Subjects:	non-steroidal anti-inflammatory drugs off-label over-the-counter drugs drug safety pharmacovigilance
Online Access:	https://www.risksafety.ru/jour/article/view/113
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020-12-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
by: E. O. Zhuravleva, et al.
Published: (2018-06-01)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

PROBLEMS OF RESPONSIBLE SELF-MEDICATION OF ALLERGY SYMPTOMS AND FARMACEUTICAL COUNSELING
by: V. A. Izrafilova, et al.
Published: (2021-03-01)

Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors
by: N. Yu. Velts, et al.
Published: (2024-10-01)

Guidelines for the planning and implementation of pharmacovigilance systems audit
by: S. V. Glagolev, et al.
Published: (2018-02-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

Season of Colds and Flu is in Full Swing: Treating Cough
by: Svetlana V. Ilyina
Published: (2018-02-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

liver disease. Clinical case of liver cirrhosis against the background of non-steroidal anti-inflammatory drugs
by: E. Yu. Plotnikova, et al.
Published: (2021-06-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

Assessment of self-treatment in terms of inappropriate prescribing registry
by: S. Yu. Martsevich, et al.
Published: (2025-04-01)

APPLICATION OF SOLID DISPERSIONS WITH NON STEROIDAL ANTI INFLAMMATORY DRUGS IN PHARMACY
by: I. I. Krasnuk (Junior), et al.
Published: (2019-01-01)

APPLICATION OF DRUG-RELATED PROBLEMS APPROACH TO ANALYSIS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS’ SAFETY
by: A. V. Matveev, et al.
Published: (2019-09-01)

Typical pharmacovigilance system master file (PSMF)
by: B. K. Romanov, et al.
Published: (2018-02-01)

Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results
by: Yu. V. Olefir, et al.
Published: (2018-02-01)

A cross-sectional study on self-medication with over-the-counter drugs among adolescents: an analysis of current practices
by: Chenyang Ma, et al.
Published: (2025-06-01)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Current Information on the Safety of Medicinal Products: Decisions of Foreign Regulatory Authorities
by: E. V. Shubnikova
Published: (2024-04-01)

Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications
by: Muhammad Hafeez, et al.
Published: (2020-05-01)

Potential role of acetylsalicilic acid and other non-steroidal anti-inflammatory drugs in cancer risk reduction (literature review)
by: V. V. Buheruk, et al.
Published: (2021-06-01)

Advantages of “Soft Steroids” in the Treatment of Inflammatory Eye Diseases. Оverview
by: D. Yu. Maychuk, et al.
Published: (2021-12-01)

Why patients fail to seek information on OTC product interactions with a direct-acting oral anticoagulant: perspectives on information-seeking
by: Marley P.D. Magee, et al.
Published: (2025-02-01)

Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease
by: N. Yu. Velts, et al.
Published: (2022-10-01)

Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)

Qualitative analysis of blood from patients engaging in deliberate self‐harm: Differences between prescribed and detected drugs
by: Masato Masuda, et al.
Published: (2024-12-01)

Analysis of the use and adverse effects of non-steroidal anti-inflammatory drugs: A pilot study
by: Perić Aneta, et al.
Published: (2006-01-01)

Assessment of knowledge, attitude, and practice of undergraduate medical students toward over-the-counter drugs: An observational study
by: Purnendu Arya, et al.
Published: (2025-01-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Therapy with non-steroidal anti-inflammatory drugs and the quality of life of patients with rheumatic diseases
by: E. Yu. Polishchuk, et al.
Published: (2022-02-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

Use of non-steroidal anti-inflammatory drugs during the COVID-19 pandemic. Resolution of the Expert Council of the Russian Society for the Prevention of Noncommunicable Diseases
by: O. M. Drapkina, et al.
Published: (2022-02-01)

Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
by: Hyun Jung Lee, et al.
Published: (2024-11-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Investigation of the analgesic efficacy of local therapy with non-steroidal anti-inflammatory drugs in patients with knee osteoarthritis
by: E. A. Strebkova, et al.
Published: (2024-10-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS
by: A. R. Titova, et al.
Published: (2018-02-01)